Amy M. Yule , Amy S.B. Bohnert , Ty A. Ridenour , Barrett Montgomery , Timothy E. Wilens , Maureen Walton , Erin E. Bonar , Lisa Saldana , Lynn E. Fiellin , Danica K. Knight , Yang Yang , Jason Williams , Sazid Khan , Liann Tucker , Feker Wondimagegnehu , Kym Ahrens
{"title":"芬太尼时代青少年和年轻人非致命性用药过量的横断面多样本研究。","authors":"Amy M. Yule , Amy S.B. Bohnert , Ty A. Ridenour , Barrett Montgomery , Timothy E. Wilens , Maureen Walton , Erin E. Bonar , Lisa Saldana , Lynn E. Fiellin , Danica K. Knight , Yang Yang , Jason Williams , Sazid Khan , Liann Tucker , Feker Wondimagegnehu , Kym Ahrens","doi":"10.1016/j.drugalcdep.2025.112921","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Overdose deaths disproportionately increased among adolescents and young adults (AYA) between 2019 and 2022, despite declining substance use. We examined the prevalence of nonfatal overdose and characteristics associated with overdose history in AYA.</div></div><div><h3>Methods</h3><div>AYA enrolled between 2020 and 2023 in five opioid use disorder prevention studies in child welfare, healthcare, and legal settings from six states were included in this analysis. Nonfatal overdose history, demographic, and clinical characteristics were assessed at baseline. Across studies, overdose history was assessed with slight variations in wording, but most other measures were standardized. Odds ratios (OR) of lifetime overdose were calculated with logistic regression for each risk factor with demographic control variables (age, sex, race) included as covariates, and reported separately by sample.</div></div><div><h3>Results</h3><div>Sample sizes ranged from 137 to 929 (total N = 1856). Characteristics across samples ranged from <em>M</em> = 16.2–26.4 years for age, and 11.7–91.9 % for female sex. For race, samples ranged from 35 % to 89.4 % White and 17.3–89.4 % Black. History of nonfatal overdose ranged from 6.6 % to 41.4 %. Statistically significant characteristics associated with overdose history in all samples included history of opioid misuse (ORs ranging from 1.98 to 6.73) and family members with a substance use problem (ORs range from 1.27 to 2.05). Frequent and early onset alcohol and cannabis use was also associated with overdose history in several samples.</div></div><div><h3>Conclusions</h3><div>Overdose prevention interventions for AYA should include a focus on AYA who misuse opioids and families with a history of substance use problems.</div></div>","PeriodicalId":11322,"journal":{"name":"Drug and alcohol dependence","volume":"276 ","pages":"Article 112921"},"PeriodicalIF":3.6000,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cross sectional multi-sample study of nonfatal overdose in adolescents and young adults in the fentanyl era\",\"authors\":\"Amy M. Yule , Amy S.B. Bohnert , Ty A. Ridenour , Barrett Montgomery , Timothy E. Wilens , Maureen Walton , Erin E. Bonar , Lisa Saldana , Lynn E. Fiellin , Danica K. Knight , Yang Yang , Jason Williams , Sazid Khan , Liann Tucker , Feker Wondimagegnehu , Kym Ahrens\",\"doi\":\"10.1016/j.drugalcdep.2025.112921\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Overdose deaths disproportionately increased among adolescents and young adults (AYA) between 2019 and 2022, despite declining substance use. We examined the prevalence of nonfatal overdose and characteristics associated with overdose history in AYA.</div></div><div><h3>Methods</h3><div>AYA enrolled between 2020 and 2023 in five opioid use disorder prevention studies in child welfare, healthcare, and legal settings from six states were included in this analysis. Nonfatal overdose history, demographic, and clinical characteristics were assessed at baseline. Across studies, overdose history was assessed with slight variations in wording, but most other measures were standardized. Odds ratios (OR) of lifetime overdose were calculated with logistic regression for each risk factor with demographic control variables (age, sex, race) included as covariates, and reported separately by sample.</div></div><div><h3>Results</h3><div>Sample sizes ranged from 137 to 929 (total N = 1856). Characteristics across samples ranged from <em>M</em> = 16.2–26.4 years for age, and 11.7–91.9 % for female sex. For race, samples ranged from 35 % to 89.4 % White and 17.3–89.4 % Black. History of nonfatal overdose ranged from 6.6 % to 41.4 %. Statistically significant characteristics associated with overdose history in all samples included history of opioid misuse (ORs ranging from 1.98 to 6.73) and family members with a substance use problem (ORs range from 1.27 to 2.05). Frequent and early onset alcohol and cannabis use was also associated with overdose history in several samples.</div></div><div><h3>Conclusions</h3><div>Overdose prevention interventions for AYA should include a focus on AYA who misuse opioids and families with a history of substance use problems.</div></div>\",\"PeriodicalId\":11322,\"journal\":{\"name\":\"Drug and alcohol dependence\",\"volume\":\"276 \",\"pages\":\"Article 112921\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and alcohol dependence\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0376871625003746\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and alcohol dependence","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0376871625003746","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Cross sectional multi-sample study of nonfatal overdose in adolescents and young adults in the fentanyl era
Introduction
Overdose deaths disproportionately increased among adolescents and young adults (AYA) between 2019 and 2022, despite declining substance use. We examined the prevalence of nonfatal overdose and characteristics associated with overdose history in AYA.
Methods
AYA enrolled between 2020 and 2023 in five opioid use disorder prevention studies in child welfare, healthcare, and legal settings from six states were included in this analysis. Nonfatal overdose history, demographic, and clinical characteristics were assessed at baseline. Across studies, overdose history was assessed with slight variations in wording, but most other measures were standardized. Odds ratios (OR) of lifetime overdose were calculated with logistic regression for each risk factor with demographic control variables (age, sex, race) included as covariates, and reported separately by sample.
Results
Sample sizes ranged from 137 to 929 (total N = 1856). Characteristics across samples ranged from M = 16.2–26.4 years for age, and 11.7–91.9 % for female sex. For race, samples ranged from 35 % to 89.4 % White and 17.3–89.4 % Black. History of nonfatal overdose ranged from 6.6 % to 41.4 %. Statistically significant characteristics associated with overdose history in all samples included history of opioid misuse (ORs ranging from 1.98 to 6.73) and family members with a substance use problem (ORs range from 1.27 to 2.05). Frequent and early onset alcohol and cannabis use was also associated with overdose history in several samples.
Conclusions
Overdose prevention interventions for AYA should include a focus on AYA who misuse opioids and families with a history of substance use problems.
期刊介绍:
Drug and Alcohol Dependence is an international journal devoted to publishing original research, scholarly reviews, commentaries, and policy analyses in the area of drug, alcohol and tobacco use and dependence. Articles range from studies of the chemistry of substances of abuse, their actions at molecular and cellular sites, in vitro and in vivo investigations of their biochemical, pharmacological and behavioural actions, laboratory-based and clinical research in humans, substance abuse treatment and prevention research, and studies employing methods from epidemiology, sociology, and economics.